Patents Assigned to Gene Logic Inc.
  • Publication number: 20080234345
    Abstract: A method is provided for reducing or alleviating inflammation or a pathological process associated therewith or secondary thereto in a subject having an inflammatory disease of the digestive tract. The method comprises administering to the subject an anti-inflammatorily effective amount of an ACE2 inhibitor.
    Type: Application
    Filed: September 7, 2007
    Publication date: September 25, 2008
    Applicant: Gene Logic Inc.
    Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Dominic Picarella
  • Publication number: 20080132474
    Abstract: A method for selecting a female breast cancer patient for AT1 receptor antagonist therapy comprises (a) determining whether the cancer comprises a tumor that is ER+ and/or PR+; and (b) selecting the patient for AT1 receptor antagonist therapy only if the cancer is determined to comprise an ER+ and/or PR+ tumor. A method for treating breast cancer in a female patient further comprises (c) administering to the patient, if so selected, an AT1 receptor antagonist according to a regimen effective to reduce growth, invasiveness and/or metastasis of the tumor.
    Type: Application
    Filed: November 6, 2007
    Publication date: June 5, 2008
    Applicant: Gene Logic Inc.
    Inventors: Robert Mark Coopersmith, David William White, Shengfang Jin, Denzyl Fernandes, Xuena Lin
  • Publication number: 20080107650
    Abstract: A method for treating an inflammatory disease of the digestive tract, for example inflammatory bowel disease, in a subject comprises administering to the subject a therapeutically effective amount of a compound selected from the group consisting of (S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid, pharmaceutically acceptable salts thereof and prodrugs thereof.
    Type: Application
    Filed: September 7, 2007
    Publication date: May 8, 2008
    Applicant: Gene Logic Inc.
    Inventors: Louis Tartaglia, Thomas Barnes, Robert Coopersmith, Scott Malstrom, David White, Dominic Picarella
  • Patent number: 7251642
    Abstract: A platform is for managing, integrating, and analyzing gene expression data. The platform includes a Run Time Engine(RTE) which provides more direct, quicker, and more efficient access to gene expression data through the use of memory mapped files. The platform also includes a workspace that is implemented in directories with data objects comprising XML descriptors coupled with binary data objects for storing gene and sample identifiers and input parameters for saved analysis sessions. The platform provides various Application Programming Interfaces (APIs) to a data warehouse, including a low-level C++ API, a high-level C++ API, a Perl API, R API, and CORBA API to access gene expression data from RTE memory mapped files. These APIs offer quicker and more direct access to the memory, thus improving the speed of overall operations.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: July 31, 2007
    Assignee: Gene Logic Inc.
    Inventor: Ernest Szeto
  • Publication number: 20070055448
    Abstract: The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known toxin. The genes and their encoded proteins may be used as toxicity markers in drug screening and toxicity assays. The invention also includes a database of genes and/or proteins characterized by toxin-induced differential expression.
    Type: Application
    Filed: August 9, 2004
    Publication date: March 8, 2007
    Applicant: Gene Logic Inc.
    Inventors: Donna Mendrick, Mark Porter, Kory Johnson, Brandon Higgs, Arthur Castle, Michael Orr, Michael Elashoff
  • Patent number: 7031843
    Abstract: The invention described herein relates to computer and display methods and systems for acquiring, storing, manipulating, analyzing, linking, retrieving and displaying the data. The methods and systems are illustrated with reference to data on constituents of biological systems, particularly data on gene expression. In this regard, the invention especially relates to interactive systems for displaying gene expression-related data in three-dimensional molecular topographies. Expressed genes and their activity are represented as peaks in the topographies. Additionally, the invention relates to methods and systems for generating and displaying delta plots, which show differences in gene expression, and to methods and systems for generating molecular movies that show changes in gene expression. While illustrated by reference to gene expression, the methods and systems can be used to generate and manipulate displays of data on other complex populations.
    Type: Grant
    Filed: September 23, 1998
    Date of Patent: April 18, 2006
    Assignee: Gene Logic Inc.
    Inventors: Brian R. Bullard, Sean Mullins
  • Patent number: 6951721
    Abstract: Methods for identifying functional allele profiles of a given gene are disclosed. Functional allele profiles comprise the commonly occurring alleles in a population, and the relative frequencies at which such alleles of a given gene occur. Functional allele profiles are useful in treatment and diagnosis of diseases, for genetic and pharmacogenetic applications and for evaluating the degree to which the gene(s) are under selective pressure.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: October 4, 2005
    Assignee: Gene Logic Inc.
    Inventor: Patricia D. Murphy
  • Patent number: 6931396
    Abstract: A multi-database query system which queries a plurality of databases and servers, including an input which receives queries in a structured form and a translation server which translates at least a part of a received query into commands recognized by a data manipulation server.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: August 16, 2005
    Assignee: Gene Logic Inc.
    Inventors: Thodoros Topaloglou, Anthony Kosky
  • Patent number: 6838256
    Abstract: isolated coding sequences and to the protein sequences they code for. This invention is directed to three coding sequence of the BRCA1 gene. The three coding sequences, BRCA1(omi1), BRCA1(omi2), and BRCA1(omi3) and their frequencies of occurrence are provided together with the protein sequences they code for. Another aspect of this invention is a method of determining the consensus sequence for any gene. Another aspect of the invention is a method of identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because they have inherited a causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with any of the isolated BRCA1 coding sequences.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: January 4, 2005
    Assignee: Gene Logic Inc.
    Inventors: Patricia D. Murphy, Antonette C. Allen, Christopher P. Alvares, Brenda S. Critz, Sheri J. Olson, Denise B. Schelter, Bin Zeng
  • Patent number: 6686163
    Abstract: The invention is directed to isolated coding sequences and to the protein sequences they code for. The coding sequence for BRCA1(omi4) gene is provided together with the protein sequence it codes for. The BRCA1(omi4) sequence is used for identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because the patient has an inherited causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with the isolated BRCA1(omi4) coding sequence and protein replacement therapy with the BRCA1(omi4) protein.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: February 3, 2004
    Assignee: Gene Logic Inc.
    Inventors: Antonette C. P. Allen, Tracy S. Angelly, Tammy Lawrence, Sheri J. Olson, Mark B. Rabin